Outcomes and predictors of readmission after implantation of a percutaneous left atrial appendage occlusion device in the United States: A propensity score‐matched analysis from The National Readmission Database
Journal of Cardiovascular Electrophysiology2021Vol. 32(11), pp. 2961–2970
Citations Over TimeTop 21% of 2021 papers
Deepak Kumar Pasupula, Muhammad Bilal Munir, Anusha Ganapati Bhat, Sudeep K Siddappa Malleshappa, Srinidhi J. Meera, Michael Spooner, Ketan Koranne, Brian Olshansky, Sameer Hirji, Jonathan C. Hsu
Abstract
The readmission rate following the LAAO procedure is substantial (approximately 10%), and largely attributable to gastrointestinal bleeding. Factors such as drug abuse and anemia must be explored further to minimize readmission risk.
Related Papers
- → Left Atrial Appendage Occlusion for The Unmet Clinical Needs of Stroke Prevention in Nonvalvular Atrial Fibrillation(2019)90 cited
- → A History of Percutaneous Left Atrial Appendage Occlusion with the PLAATO Device(2018)7 cited
- → Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device(2008)19 cited
- → Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device(2017)3 cited